TY - STD TI - Elfishawi MM, Zleik N, Kvrgic Z, Michet CJ Jr, Crowson CS, Matteson EL, et al. The rising incidence of gout and the increasing burden of comorbidities: a population-based study over 20 years. J Rheumatol. 2018;45(4):574–9. ID - ref1 ER - TY - JOUR AU - Richette, P. AU - Bardin, T. PY - 2010 DA - 2010// JO - Gout. Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(09)60883-7 DO - 10.1016/S0140-6736(09)60883-7 ID - Richette2010 ER - TY - JOUR AU - Annemans, L. AU - Spaepen, E. AU - Gaskin, M. AU - Bonnemaire, M. AU - Malier, V. AU - Gilbert, T. PY - 2008 DA - 2008// TI - Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005 JO - Ann Rheum Dis VL - 67 UR - https://doi.org/10.1136/ard.2007.076232 DO - 10.1136/ard.2007.076232 ID - Annemans2008 ER - TY - STD TI - Kiadaliri AA, Uhlig T, Englund M. Burden of gout in the Nordic region, 1990-2015: findings from the Global Burden of Disease Study 2015. Scand J Rheumatol. 2018;47(5):410–7. ID - ref4 ER - TY - JOUR AU - Kuo, C. F. AU - Grainge, M. J. AU - Mallen, C. AU - Zhang, W. AU - Doherty, M. PY - 2015 DA - 2015// TI - Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study JO - Ann Rheum Dis VL - 74 UR - https://doi.org/10.1136/annrheumdis-2013-204463 DO - 10.1136/annrheumdis-2013-204463 ID - Kuo2015 ER - TY - JOUR AU - Zhu, Y. AU - Pandya, B. J. AU - Choi, H. K. PY - 2011 DA - 2011// TI - Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008 JO - Arthritis Rheum VL - 63 UR - https://doi.org/10.1002/art.30520 DO - 10.1002/art.30520 ID - Zhu2011 ER - TY - JOUR AU - Martillo, M. A. AU - Nazzal, L. AU - Crittenden, D. B. PY - 2014 DA - 2014// TI - The crystallization of monosodium urate JO - Curr Rheumatol Rep VL - 16 UR - https://doi.org/10.1007/s11926-013-0400-9 DO - 10.1007/s11926-013-0400-9 ID - Martillo2014 ER - TY - JOUR AU - Schlesinger, N. AU - Norquist, J. M. AU - Watson, D. J. PY - 2009 DA - 2009// TI - Serum urate during acute gout JO - J Rheumatol VL - 36 UR - https://doi.org/10.3899/jrheum.080938 DO - 10.3899/jrheum.080938 ID - Schlesinger2009 ER - TY - JOUR AU - Martinon, F. AU - Petrilli, V. AU - Mayor, A. AU - Tardivel, A. AU - Tschopp, J. PY - 2006 DA - 2006// TI - Gout-associated uric acid crystals activate the NALP3 inflammasome JO - Nature VL - 440 UR - https://doi.org/10.1038/nature04516 DO - 10.1038/nature04516 ID - Martinon2006 ER - TY - JOUR AU - Joosten, L. A. AU - Netea, M. G. AU - Mylona, E. AU - Koenders, M. I. AU - Malireddi, R. K. AU - Oosting, M. PY - 2010 DA - 2010// TI - Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1beta production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis JO - Arthritis Rheum VL - 62 UR - https://doi.org/10.1002/art.27667 DO - 10.1002/art.27667 ID - Joosten2010 ER - TY - JOUR AU - Cleophas, M. C. AU - Lemmers, H. AU - Toenhake-Dijkstra, H. AU - Fossati, G. AU - Jansen, T. L. PY - 2016 DA - 2016// TI - Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases JO - Ann Rheum Dis VL - 75 UR - https://doi.org/10.1136/annrheumdis-2014-206258 DO - 10.1136/annrheumdis-2014-206258 ID - Cleophas2016 ER - TY - JOUR AU - Richette, P. AU - Doherty, M. AU - Pascual, E. AU - Barskova, V. AU - Becce, F. AU - Castaneda-Sanabria, J. PY - 2017 DA - 2017// TI - 2016 updated EULAR evidence-based recommendations for the management of gout JO - Ann Rheum Dis VL - 76 UR - https://doi.org/10.1136/annrheumdis-2016-209707 DO - 10.1136/annrheumdis-2016-209707 ID - Richette2017 ER - TY - JOUR AU - Keenan, R. T. AU - O'Brien, W. R. AU - Lee, K. H. AU - Crittenden, D. B. AU - Fisher, M. C. AU - Goldfarb, D. S. PY - 2011 DA - 2011// TI - Prevalence of contraindications and prescription of pharmacologic therapies for gout JO - Am J Med VL - 124 UR - https://doi.org/10.1016/j.amjmed.2010.09.012 DO - 10.1016/j.amjmed.2010.09.012 ID - Keenan2011 ER - TY - JOUR AU - Gu, T. AU - Shah, N. AU - Deshpande, G. AU - Tang, D. H. AU - Eisenberg, D. F. PY - 2016 DA - 2016// TI - Comparing biologic cost per treated patient across indications among adult US managed care patients: a retrospective cohort study JO - Drugs Real World Outcomes VL - 3 UR - https://doi.org/10.1007/s40801-016-0093-2 DO - 10.1007/s40801-016-0093-2 ID - Gu2016 ER - TY - JOUR AU - Choudhary, C. AU - Kumar, C. AU - Gnad, F. AU - Nielsen, M. L. AU - Rehman, M. AU - Walther, T. C. PY - 2009 DA - 2009// TI - Lysine acetylation targets protein complexes and co-regulates major cellular functions JO - Science VL - 325 UR - https://doi.org/10.1126/science.1175371 DO - 10.1126/science.1175371 ID - Choudhary2009 ER - TY - JOUR AU - Seto, E. AU - Yoshida, M. PY - 2014 DA - 2014// TI - Erasers of histone acetylation: the histone deacetylase enzymes JO - Cold Spring Harb Perspect Biol VL - 6 UR - https://doi.org/10.1101/cshperspect.a018713 DO - 10.1101/cshperspect.a018713 ID - Seto2014 ER - TY - JOUR AU - Yang, X. J. AU - Seto, E. PY - 2008 DA - 2008// TI - The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men JO - Nat Rev Mol Cell Biol VL - 9 UR - https://doi.org/10.1038/nrm2346 DO - 10.1038/nrm2346 ID - Yang2008 ER - TY - JOUR AU - West, A. C. AU - Johnstone, R. W. PY - 2014 DA - 2014// TI - New and emerging HDAC inhibitors for cancer treatment JO - J Clin Invest VL - 124 UR - https://doi.org/10.1172/JCI69738 DO - 10.1172/JCI69738 ID - West2014 ER - TY - JOUR AU - Pan, L. AU - Lu, J. AU - Wang, X. AU - Han, L. AU - Zhang, Y. AU - Han, S. PY - 2007 DA - 2007// TI - Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression JO - Cancer VL - 109 UR - https://doi.org/10.1002/cncr.22585 DO - 10.1002/cncr.22585 ID - Pan2007 ER - TY - JOUR AU - Zhang, H. AU - Zhao, B. AU - Huang, C. AU - Meng, X. M. AU - Bian, E. B. AU - Li, J. PY - 2014 DA - 2014// TI - Melittin restores PTEN expression by down-regulating HDAC2 in human hepatocelluar carcinoma HepG2 cells JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0095520 DO - 10.1371/journal.pone.0095520 ID - Zhang2014 ER - TY - JOUR AU - Gan, Y. H. AU - Zhang, S. PY - 2009 DA - 2009// TI - PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells JO - Oral Oncol VL - 45 UR - https://doi.org/10.1016/j.oraloncology.2009.05.563 DO - 10.1016/j.oraloncology.2009.05.563 ID - Gan2009 ER - TY - JOUR AU - Dhar, S. AU - Kumar, A. AU - Li, K. AU - Tzivion, G. AU - Levenson, A. S. PY - 1853 DA - 1853// TI - Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer JO - Biochim Biophys Acta VL - 2015 ID - Dhar1853 ER - TY - JOUR AU - Cheng, S. C. AU - Quintin, J. AU - Cramer, R. A. AU - Shepardson, K. M. AU - Saeed, S. AU - Kumar, V. PY - 2014 DA - 2014// TI - mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity JO - Science VL - 345 UR - https://doi.org/10.1126/science.1250684 DO - 10.1126/science.1250684 ID - Cheng2014 ER - TY - JOUR AU - Fruman, D. A. AU - Chiu, H. AU - Hopkins, B. D. AU - Bagrodia, S. AU - Cantley, L. C. AU - Abraham, R. T. PY - 2017 DA - 2017// TI - The PI3K pathway in human disease JO - Cell VL - 170 UR - https://doi.org/10.1016/j.cell.2017.07.029 DO - 10.1016/j.cell.2017.07.029 ID - Fruman2017 ER - TY - JOUR AU - Crisan, T. O. AU - Cleophas, M. C. P. AU - Novakovic, B. AU - Erler, K. AU - Veerdonk, F. L. AU - Stunnenberg, H. G. PY - 2017 DA - 2017// TI - Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway JO - Proc Natl Acad Sci U S A VL - 114 UR - https://doi.org/10.1073/pnas.1620910114 DO - 10.1073/pnas.1620910114 ID - Crisan2017 ER - TY - JOUR AU - Deberardinis, R. J. AU - Lum, J. J. AU - Thompson, C. B. PY - 2006 DA - 2006// TI - Phosphatidylinositol 3-kinase-dependent modulation of carnitine palmitoyltransferase 1A expression regulates lipid metabolism during hematopoietic cell growth JO - J Biol Chem VL - 281 UR - https://doi.org/10.1074/jbc.M608372200 DO - 10.1074/jbc.M608372200 ID - Deberardinis2006 ER - TY - JOUR AU - Shiojima, I. AU - Walsh, K. PY - 2006 DA - 2006// TI - Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway JO - Genes Dev VL - 20 UR - https://doi.org/10.1101/gad.1492806 DO - 10.1101/gad.1492806 ID - Shiojima2006 ER - TY - JOUR AU - Ungureanu, D. AU - Saharinen, P. AU - Junttila, I. AU - Hilton, D. J. AU - Silvennoinen, O. PY - 2002 DA - 2002// TI - Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1 JO - Mol Cell Biol VL - 22 UR - https://doi.org/10.1128/MCB.22.10.3316-3326.2002 DO - 10.1128/MCB.22.10.3316-3326.2002 ID - Ungureanu2002 ER - TY - JOUR AU - Ryo, A. AU - Suizu, F. AU - Yoshida, Y. AU - Perrem, K. AU - Liou, Y. C. AU - Wulf, G. PY - 2003 DA - 2003// TI - Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA JO - Mol Cell VL - 12 UR - https://doi.org/10.1016/S1097-2765(03)00490-8 DO - 10.1016/S1097-2765(03)00490-8 ID - Ryo2003 ER - TY - JOUR AU - Mansell, A. AU - Smith, R. AU - Doyle, S. L. AU - Gray, P. AU - Fenner, J. E. AU - Crack, P. J. PY - 2006 DA - 2006// TI - Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating mal degradation JO - Nat Immunol VL - 7 UR - https://doi.org/10.1038/ni1299 DO - 10.1038/ni1299 ID - Mansell2006 ER - TY - JOUR AU - Dinarello, C. A. AU - Fossati, G. AU - Mascagni, P. PY - 2011 DA - 2011// TI - Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer JO - Mol Med VL - 17 UR - https://doi.org/10.2119/molmed.2011.00116 DO - 10.2119/molmed.2011.00116 ID - Dinarello2011 ER - TY - JOUR AU - Lin, H. S. AU - Hu, C. Y. AU - Chan, H. Y. AU - Liew, Y. Y. AU - Huang, H. P. AU - Lepescheux, L. PY - 2007 DA - 2007// TI - Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents JO - Br J Pharmacol VL - 150 UR - https://doi.org/10.1038/sj.bjp.0707165 DO - 10.1038/sj.bjp.0707165 ID - Lin2007 ER - TY - JOUR AU - Joosten, L. A. AU - Leoni, F. AU - Meghji, S. AU - Mascagni, P. PY - 2011 DA - 2011// TI - Inhibition of HDAC activity by ITF2357 ameliorates joint inflammation and prevents cartilage and bone destruction in experimental arthritis JO - Mol Med VL - 17 UR - https://doi.org/10.2119/molmed.2011.00058 DO - 10.2119/molmed.2011.00058 ID - Joosten2011 ER - TY - JOUR AU - Nasu, Y. AU - Nishida, K. AU - Miyazawa, S. AU - Komiyama, T. AU - Kadota, Y. AU - Abe, N. PY - 2008 DA - 2008// TI - Trichostatin a, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model JO - Osteoarthr Cartil VL - 16 UR - https://doi.org/10.1016/j.joca.2007.10.014 DO - 10.1016/j.joca.2007.10.014 ID - Nasu2008 ER - TY - JOUR AU - Vojinovic, J. AU - Damjanov, N. AU - D'Urzo, C. AU - Furlan, A. AU - Susic, G. AU - Pasic, S. PY - 2011 DA - 2011// TI - Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis JO - Arthritis Rheum VL - 63 UR - https://doi.org/10.1002/art.30238 DO - 10.1002/art.30238 ID - Vojinovic2011 ER - TY - JOUR AU - Cantley, M. D. AU - Haynes, D. R. PY - 2013 DA - 2013// TI - Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs JO - Inflammopharmacology VL - 21 UR - https://doi.org/10.1007/s10787-012-0166-0 DO - 10.1007/s10787-012-0166-0 ID - Cantley2013 ER - TY - JOUR AU - Shakespear, M. R. AU - Halili, M. A. AU - Irvine, K. M. AU - Fairlie, D. P. AU - Sweet, M. J. PY - 2011 DA - 2011// TI - Histone deacetylases as regulators of inflammation and immunity JO - Trends Immunol VL - 32 UR - https://doi.org/10.1016/j.it.2011.04.001 DO - 10.1016/j.it.2011.04.001 ID - Shakespear2011 ER - TY - JOUR AU - Lagger, G. AU - O’Carroll, D. AU - Rembold, M. AU - Khier, H. AU - Tischler, J. AU - Weitzer, G. PY - 2002 DA - 2002// TI - Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression JO - EMBO J VL - 21 UR - https://doi.org/10.1093/emboj/21.11.2672 DO - 10.1093/emboj/21.11.2672 ID - Lagger2002 ER - TY - JOUR AU - Montgomery, R. L. AU - Davis, C. A. AU - Potthoff, M. J. AU - Haberland, M. AU - Fielitz, J. AU - Qi, X. PY - 2007 DA - 2007// TI - Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility JO - Genes Dev VL - 21 UR - https://doi.org/10.1101/gad.1563807 DO - 10.1101/gad.1563807 ID - Montgomery2007 ER - TY - JOUR AU - Ruijter, A. J. M. AU - Gennip, A. H. AU - Caron, H. N. AU - Kemp, S. AU - Kuilenburg, A. B. P. PY - 2003 DA - 2003// TI - Histone deacetylases (HDACs): characterization of the classical HDAC family JO - Biochem J VL - 370 UR - https://doi.org/10.1042/bj20021321 DO - 10.1042/bj20021321 ID - Ruijter2003 ER - TY - JOUR AU - Hubbert, C. AU - Guardiola, A. AU - Shao, R. AU - Kawaguchi, Y. AU - Ito, A. AU - Nixon, A. PY - 2002 DA - 2002// TI - HDAC6 is a microtubule-associated deacetylase JO - Nature VL - 417 UR - https://doi.org/10.1038/417455a DO - 10.1038/417455a ID - Hubbert2002 ER - TY - JOUR AU - Misawa, T. AU - Takahama, M. AU - Kozaki, T. AU - Lee, H. AU - Zou, J. AU - Saitoh, T. PY - 2013 DA - 2013// TI - Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome JO - Nat Immunol VL - 14 UR - https://doi.org/10.1038/ni.2550 DO - 10.1038/ni.2550 ID - Misawa2013 ER - TY - STD TI - Ashburner BP, Westerheide SD, Baldwin AS. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol. 2001;21(20):7065–77. ID - ref43 ER - TY - STD TI - Chen L-F, Fischle W, Verdin E, Greene WC. Duration of Nuclear NF-kappa B Action Regulated by Reversible Acetylation. Science. 2001;293(5535):1653–7. ID - ref44 ER - TY - STD TI - Chen L-F, Williams SA, Mu Y, Nakano H, Duerr JM, Buckbinder L, et al. NF-κB RelA phosphorylation regulates RelA acetylation. Mol Cell Biol. 2005;25(18):7966–75. ID - ref45 ER - TY - STD TI - Choi YS, Jeong S. PI3-kinase and PDK-1 regulate HDAC1-mediated transcriptional repression of transcription factor NF-kappaB. Mol Cells. 2005;20(2):241–6. ID - ref46 ER - TY - JOUR AU - Dan, H. C. AU - Cooper, M. J. AU - Cogswell, P. C. AU - Duncan, J. A. AU - Ting, J. P. AU - Baldwin, A. S. PY - 2008 DA - 2008// TI - Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and raptor in association with IKK JO - Genes Dev VL - 22 UR - https://doi.org/10.1101/gad.1662308 DO - 10.1101/gad.1662308 ID - Dan2008 ER - TY - STD TI - Administration UFaD. ISTODAX (romidepsin) Label. 2009. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022393lbl.pdf. [updated 06-11-2009. Accessed 30 May 2018]. UR - https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022393lbl.pdf ID - ref48 ER - TY - JOUR AU - Rafehi, H. AU - Balcerczyk, A. AU - Lunke, S. AU - Kaspi, A. AU - Ziemann, M. AU - Kn, H. PY - 2014 DA - 2014// TI - Vascular histone deacetylation by pharmacological HDAC inhibition JO - Genome Res VL - 24 UR - https://doi.org/10.1101/gr.168781.113 DO - 10.1101/gr.168781.113 ID - Rafehi2014 ER - TY - JOUR AU - Bannister, A. J. AU - Kouzarides, T. PY - 2011 DA - 2011// TI - Regulation of chromatin by histone modifications JO - Cell Res VL - 21 UR - https://doi.org/10.1038/cr.2011.22 DO - 10.1038/cr.2011.22 ID - Bannister2011 ER -